Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration

Guanghui Gao, Jian Ni, Yina Wang, Shengxiang Ren, Zhihua Liu, Gongyan Chen, Kangsheng Gu, Aimin Zang, Jun Zhao, Renhua Guo, Jianxing He, Xiaoyan Lin, Yueyin Pan, Zhiyong Ma, Zhehai Wang, Min Fan, Yunpeng Liu, Shundong Cang, Xinfeng Yang, Weixia Li, Quanren Wang, Caicun Zhou